Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

α-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies
G. Bellomo, Chiara Maria Giulia De Luca, Federico Paolini Paoletti, et al.
Neurology (2022) Vol. 99, Iss. 5, pp. 195-205
Closed Access | Times Cited: 86

Showing 1-25 of 86 citing articles:

Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study
Andrew Siderowf, Luis Concha‐Marambio, David-Erick Lafontant, et al.
The Lancet Neurology (2023) Vol. 22, Iss. 5, pp. 407-417
Open Access | Times Cited: 350
A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research
Tanya Simuni, Lana M. Chahine, Kathleen L. Poston, et al.
The Lancet Neurology (2024) Vol. 23, Iss. 2, pp. 178-190
Closed Access | Times Cited: 211
A biological classification of Parkinson's disease: the SynNeurGe research diagnostic criteria
Günter U. Höglinger, Charles H. Adler, Daniela Berg, et al.
The Lancet Neurology (2024) Vol. 23, Iss. 2, pp. 191-204
Closed Access | Times Cited: 203
Cognitive effects of Lewy body pathology in clinically unimpaired individuals
Sebastian Palmqvist, Marcello Rossi, Sara Hall, et al.
Nature Medicine (2023) Vol. 29, Iss. 8, pp. 1971-1978
Open Access | Times Cited: 75
Clinical effects of Lewy body pathology in cognitively impaired individuals
Corinne Quadalti, Sebastian Palmqvist, Sara Hall, et al.
Nature Medicine (2023) Vol. 29, Iss. 8, pp. 1964-1970
Open Access | Times Cited: 75
Proposal for a Biologic Staging System of Parkinson’s Disease
Lana M. Chahine, Kalpana Merchant, Andrew Siderowf, et al.
Journal of Parkinson s Disease (2023) Vol. 13, Iss. 3, pp. 297-309
Open Access | Times Cited: 56
Clinical Diagnostic Accuracy of Parkinson's Disease: Where Do We Stand?
Sasivimol Virameteekul, Tamás Révész, Zane Jaunmuktane, et al.
Movement Disorders (2023) Vol. 38, Iss. 4, pp. 558-566
Closed Access | Times Cited: 51
Parkinson’s Disease
Caroline M. Tanner, Jill L. Ostrem
New England Journal of Medicine (2024) Vol. 391, Iss. 5, pp. 442-452
Closed Access | Times Cited: 29
Investigating alpha‐synuclein co‐pathology in Alzheimer's disease by means of cerebrospinal fluid alpha‐synuclein seed amplification assay
G. Bellomo, Andrea Toja, Federico Paolini Paoletti, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 4, pp. 2444-2452
Open Access | Times Cited: 26
Synucleins: New Data on Misfolding, Aggregation and Role in Diseases
Andrei Surguchov, Alexei Surguchev
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3241-3241
Open Access | Times Cited: 44
The role of cerebrospinal fluid and other biomarker modalities in the Alzheimer’s disease diagnostic revolution
Suzanne E. Schindler, Alireza Atri
Nature Aging (2023) Vol. 3, Iss. 5, pp. 460-462
Closed Access | Times Cited: 29
Cerebrospinal fluid lipoproteins inhibit α-synuclein aggregation by interacting with oligomeric species in seed amplification assays
G. Bellomo, Silvia Paciotti, Luis Concha‐Marambio, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 28
CSF Synaptic Biomarkers in AT(N)-Based Subgroups of Lewy Body Disease
Lorenzo Barba, Samir Abu‐Rumeileh, Steffen Halbgebauer, et al.
Neurology (2023) Vol. 101, Iss. 1
Open Access | Times Cited: 23
Defining Parkinson’s Disease: Past and Future
Kristína Kulcsarová, Matěj Škorvánek, Ronald B. Postuma, et al.
Journal of Parkinson s Disease (2024) Vol. 14, Iss. s2, pp. S257-S271
Open Access | Times Cited: 9
Research Priorities on the Role of α‐Synuclein in Parkinson's Disease Pathogenesis
Jacqueline Burré, Robert H. Edwards, Glenda M. Halliday, et al.
Movement Disorders (2024) Vol. 39, Iss. 10, pp. 1663-1678
Open Access | Times Cited: 8
Methods to Discover and Validate Biofluid-Based Biomarkers in Neurodegenerative Dementias
Charlotte E. Teunissen, Leighann Kimble, Sherif Bayoumy, et al.
Molecular & Cellular Proteomics (2023) Vol. 22, Iss. 10, pp. 100629-100629
Open Access | Times Cited: 20
Central and peripheral α‐synuclein in Parkinson disease detected by seed amplification assay
Lana M. Chahine, Thomas G. Beach, Charles H. Adler, et al.
Annals of Clinical and Translational Neurology (2023) Vol. 10, Iss. 5, pp. 696-705
Open Access | Times Cited: 18
How should we be using biomarkers in trials of disease modification in Parkinson’s disease?
Nirosen Vijiaratnam, Thomas Foltynie
Brain (2023) Vol. 146, Iss. 12, pp. 4845-4869
Open Access | Times Cited: 17
Clinical and diagnostic implications of Alzheimer’s disease copathology in Lewy body disease
Lorenzo Barba, Samir Abu‐Rumeileh, Henryk Barthel, et al.
Brain (2024) Vol. 147, Iss. 10, pp. 3325-3343
Closed Access | Times Cited: 7
Potential of the nanoplatform and PROTAC interface to achieve targeted protein degradation through the Ubiquitin–Proteasome system
Hanshu Xie, Chao Zhang
European Journal of Medicinal Chemistry (2024) Vol. 267, pp. 116168-116168
Closed Access | Times Cited: 5
A systematic review of salivary biomarkers in Parkinson’s disease
M Bartolo, Daniele Belvisi, Romina Mancinelli, et al.
Neural Regeneration Research (2024) Vol. 19, Iss. 12, pp. 2613-2625
Open Access | Times Cited: 5
α-Synuclein: A Promising Biomarker for Parkinson’s Disease and Related Disorders
Taku Hatano, Ayami Okuzumi, Gen Matsumoto, et al.
Journal of Movement Disorders (2024) Vol. 17, Iss. 2, pp. 127-137
Open Access | Times Cited: 5
Advancing Parkinson’s diagnosis: seed amplification assay for α-synuclein detection in minimally invasive samples
Elizabeth Carrazana, Leonardo Montalbán-Gutiérrez, Pedro Chaná‐Cuevas, et al.
Molecular and Cellular Biochemistry (2025)
Closed Access
Enhancing sleep quality in synucleinopathies through physical exercise
Jacopo Canonichesi, Laura Bellingacci, Francesco Rivelli, et al.
Frontiers in Cellular Neuroscience (2025) Vol. 19
Open Access
Seeding amplification assay: Limitations and insights for enhanced clinical and research applications
Ilham Y. Abdi, Sara A Hashish, Omar M. A. El‐Agnaf
Journal of Parkinson s Disease (2025)
Open Access
Page 1 - Next Page

Scroll to top